Jennings L C, MacDiarmid R D, Miles J A
N Z Med J. 1980 Sep 24;92(668):230-3.
An evaluation of the efficacy of influenza virus subunit vaccine was undertaken during a study of acute respiratory disease in the semi-isolated community of Port Chalmers, New Zealand. In 1973, the administration of a vaccine containing A/England/42/72(H3N2) and B/Roma/1/67 stains was found to produce HI antibody titres greater than or equal to 1:40 to the A and B components in 50 percent of 32 subjects. There was no significant NI antibody response to the A component. During an epidemic of A/Port Chalmers/I/73(H3N2) occurring three to four months after vaccination, vaccinees were not protected from clinical infection. Sixty and ninety-nine subjects received vaccine containing A/Port Chalmers/1/73 and B/Hong Kong/8/73 in 1974 and 1975 respectively. In 1974 all 60 subjects received a second dose of vaccine which was shown to have little effect on the distribution of HI antibody titres. The benefits of annual vaccination in this general practice are unclear.
在对新西兰查尔默斯港半隔离社区的急性呼吸道疾病研究期间,对流感病毒亚单位疫苗的疗效进行了评估。1973年,发现给32名受试者中的50%接种含有A/英格兰/42/72(H3N2)和B/罗马/1/67毒株的疫苗后,其针对A和B组分产生的血凝抑制(HI)抗体效价大于或等于1:40。对A组分没有显著的神经氨酸酶(NI)抗体反应。在接种疫苗三到四个月后发生A/查尔默斯港/I/73(H3N2)疫情期间,接种疫苗者未能免受临床感染。1974年和1975年分别有60名和99名受试者接种了含有A/查尔默斯港/1/73和B/香港/8/73的疫苗。1974年,所有60名受试者都接种了第二剂疫苗,结果显示这对HI抗体效价的分布几乎没有影响。在这种常规做法中每年接种疫苗的益处尚不清楚。